The NIFTY Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.

Nifty Pharma Index

This index consists of sector specific companies

Sectoral

Low Risk

Index

Loss of Share Certificates

Cash Dividend

Pharmaceutical industry rebounds in March at 10.3% growth: Ind-Ra

This was led by volume growth of 1.6 per cent, price growth of 5.1 per cent and products launches at 3.6 per cent

Nifty Pharma tops 325 pts amid rapid Covid-19 vaccination drive; Cadila, Aurobindo, Sun Pharma top bulls

Nifty Pharma has outperformed benchmark Nifty 50.

Sensex, Nifty snap 3-day rising streak; pharma shares rally

The domestic equity benchmarks ended with small losses after a volatile day on Friday. Pharma, IT, FMCG and PSU banks shares advanced. The barometer index, the S&P BSE Sensex, declined 154.89 points or 0.31% to 49,591.32. The Nifty 50 index lost